Suïssa - italià - Swissmedic (Swiss Agency for Therapeutic Products)

similasan ag - calcium fluoratum (hab) d12 (ph.eur. 4.1.1), clematis recta (hab) d6, natrium chloratum (hab) d12, rhus toxicodendron (hab) d8 - creme - calcium fluoratum (hab) d12 (ph.eur. 4.1.1) 25.0 mg, clematis recta (hab) d6 25.0 mg, natrium chloratum (hab) d12 25.0 mg, rhus toxicodendron (hab) d8 25.0 mg, arachidis oleum hydrogenatum 200 mg, alcohol cetylicus 100 mg, polysorbatum 60 50 mg, propylenglycolum 200 mg, aqua ad iniectabile, natrii chloroargentas, ad unguentum pro 1 g. - gemäss homöopathischem arzneimittelbild bei schmerzhaften lippenbläschen (herpes labialis), rissen, entzündungen und wundheit der lippen und mundwinkel bei herpesvirus-befall - farmaci omeopatici

Suïssa - italià - Swissmedic (Swiss Agency for Therapeutic Products)

galderma schweiz ag - terbinafini hydrochloridum - creme - terbinafini hydrochloridum 10 mg, conserv.: alcohol benzylicus, excipiens ad unguentum pro 1 g. - mittel gegen pilze - synthetika human

Unió Europea - italià - EMA (European Medicines Agency)

intervet international bv - f4ab (k88ab) fimbrial adhesin, f4ac (k88ac) fimbrial adhesin, f5 (k99) fimbrial adhesin, f6 (987p) fimbrial adhesin, lt tetanico - immunologici - suini (scrofette e scrofe) - per l'immunizzazione passiva dei suinetti mediante immunizzazione attiva di scrofe / scrofette per ridurre la mortalità e segni clinici come la diarrea dovuta a enterotossicosi neonatale durante i primi giorni di vita, causata da. ceppi di coli che esprimono le adesioni fimbriali f4ab (k88ab), f4ac (k88ac), f5 (k99) o f6 (987p).

Suïssa - italià - Swissmedic (Swiss Agency for Therapeutic Products)

haleon schweiz ag - diclofenacum kalicum - confetti - diclofenacum kalicum 25 mg, silica colloidalis anhydrica, tricalcii phosphas, magnesii stearas, maydis amylum, povidonum k 30, carboxymethylamylum natricum a corresp. natrium 0.42 mg, Überzug: cellulosum microcristallinum, macrogolum 8000, povidonum k 30, saccharum 45.42 mg, talcum, macrogolum 8000, saccharum traces, e 171, e 172 (rubrum), pro compresso obducto. - analgesico - synthetika

Itàlia - italià - Ministero della Salute

gdp srl-general dietet.pharma -

Suïssa - italià - Swissmedic (Swiss Agency for Therapeutic Products)

haleon schweiz ag - diclofenacum kalicum - confetti - diclofenacum kalicum 25 mg, silica colloidalis anhydrica, tricalcii phosphas, magnesii stearas, maydis amylum, povidonum k 30, carboxymethylamylum natricum a corresp. natrium 0.42 mg, Überzug: cellulosum microcristallinum, macrogolum 8000, povidonum k 30, saccharum 45.42 mg, talcum, macrogolum 8000, saccharum traces, e 171, e 172 (rubrum), pro compresso obducto. - analgesico - synthetika

Unió Europea - italià - EMA (European Medicines Agency)

dynavax gmbh - antigene di superficie dell'epatite b. - epatite b - vaccini - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Unió Europea - italià - EMA (European Medicines Agency)

vbi vaccines b.v. - antigene di superficie dell'epatite b. - epatite b - vaccini - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.

Suïssa - italià - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - molsidominum - compresse - molsidominum 4 mg, lactosum monohydricum 260 mg, crospovidonum, magnesii stearas, macrogolum 6000, pro compresso. - koronare herzkrankheit - synthetika

Suïssa - italià - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - nadroparinum calcicum - soluzione iniettabile - nadroparinum calcicum ca. 100 mg corresp. 11400 u.i., aqua ad iniectabile q.s. ad solutionem pro 0.6 ml. - trattamento della trombosi venosa profonda - biotechnologika